Literature DB >> 24582849

The antinociceptive effect of intravenous imipramine in colorectal distension-induced visceral pain in rats: the role of serotonergic and noradrenergic receptors.

Fatih İlkaya1, S Sırrı Bilge2, Ayhan Bozkurt3, Duygu B Baş4, Arzu Erdal2, Engin Çiftçioğlu5, Yüksel Kesim2.   

Abstract

It has been shown that imipramine, a tricyclic antidepressant (TCA), is a potent analgesic agent. However, the effect of imipramine on visceral pain has not been extensively investigated. In the current study, our aim was to characterise the putative analgesic effect of intravenous imipramine on visceral pain in rats. Our second aim was to assess the involvement of serotonergic (5-HT₂,₃,₄) and noradrenergic (α(2A, 2B, 2C)) receptor subtypes in this putative antinociceptive effect of imipramine. Male Sprague Dawley rats (250-300 g) were implanted with venous catheters for drug administration and implanted with enamelled nichrome electrodes for electromyography of the external oblique muscles. Noxious visceral stimulation was applied via by colorectal distension (CRD). The visceromotor responses (VMRs) to CRD were quantified electromyographically before and after imipramine administration at 5, 15, 30, 60, 90 and 120 min. In the antagonist groups, the agents were administered 10 min before imipramine. The administration of imipramine (5-40 mg/kg) produced a dose-dependent reduction in VMR. The administration of yohimbine (a nonselective α₂-adrenoceptor antagonist, 1 mg/kg), BRL-44408 (an α(2A)-adrenoceptor antagonist, 1 mg/kg) or MK-912 (an α2C-adrenoceptor antagonist, 300 μg/kg) but not imiloxan (an α(2B)-adrenoceptor antagonist, 1 mg/kg) inhibited the antinociceptive effect of imipramine (20 mg/kg). Additionally, ketanserin (a 5-HT₂ receptor antagonist, 0.5, 1, and 2 mg/kg) and GR113808 (a 5-HT₄ receptor antagonist, 1 mg/kg) enhanced, and ondansetron (a 5-HT₃ receptor antagonist, 0.5, 1, and 2 mg/kg) failed to alter the imipramine-induced antinociceptive effect. Our data demonstrated that, in the CDR-induced rat visceral pain model, intravenous imipramine appeared to have antinociceptive potential and that α(2A)-/α(2C)-adrenoceptors and 5-HT₂/5-HT₄ receptors may be responsible for the antinociceptive effect of imipramine on visceral pain in rats.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenergic receptors; Antinociception; Colorectal distension; Imipramine; Serotonergic receptors; Visceral pain

Mesh:

Substances:

Year:  2014        PMID: 24582849     DOI: 10.1016/j.pbb.2014.02.017

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  A Simple, Rapid and Reliable Method to Determine Imipramine and Desipramine in Mouse Serum Using Ultra-High-Performance Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry.

Authors:  Jing Zhao; Yujin Shin; Kwang-Hoon Chun; Hye-Ran Yoon; Jeongmi Lee
Journal:  J Chromatogr Sci       Date:  2015-12-19       Impact factor: 1.618

2.  Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial.

Authors:  Jürg Schliessbach; Andreas Siegenthaler; Lukas Bütikofer; Andreas Limacher; Peter Juni; Pascal H Vuilleumier; Ulrike Stamer; Lars Arendt-Nielsen; Michele Curatolo
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

3.  Decursinol-mediated antinociception and anti-allodynia in acute and neuropathic pain models in male mice: Tolerance and receptor profiling.

Authors:  LaTaijah C Crawford; Sangyub Kim; Deepkamal Karelia; Diana E Sepulveda; Daniel J Morgan; Junxuan Lü; Angela N Henderson-Redmond
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.